Anti-wrinkle serums disappoint Consumer Reports
This article was originally published in The Rose Sheet
Executive SummaryConsumers looking to fight the signs of aging should spend money on sunscreens and moisturizers rather than nine over-the-counter anti-wrinkle face serums tested by Consumer Reports, the non-profit organization asserts in an April 6 release. Featured in the May issue of Consumer Reports magazine, the test on 79 participants between the ages of 40 and 65 found that results of the serums were inconsistent, some serums producing a visual change in wrinkle length or depth for some test subjects while doing nothing for others, though all the serums claim to reduce the appearance of fine lines and wrinkles within six weeks or less. "When there were any wrinkle reductions, they were at best slight and fell short of the miracles implied on the product labels," says the organization. Of the products tested, two serums were rated as slightly more effective than others: DermaSilk 5 Minute Face Lift and Neutrogena Ageless Intensives Deep Wrinkle. Burt's Bees Naturally Ageless Intensive Repairing was found to be the least effective at reducing wrinkles, Consumer Reports says. The report is one of three on the anti-aging market and products that promise to turn back the clock
You may also be interested in...
The French drugmaker is paying $2.5bn to get hold of THOR-707 which it claims has the potential to become the best-in-class IL-2 therapeutic for solid tumors, thanks to improved pharmacology and less frequent dosing.
For the first time, a working group within the International Council for Harmonization has started work on a regulatory topic specifically tailored to the global generics and biosimilars industry.
In 2019, Mylan moved up to become the world’s leading generics, biosimilars and OTC player, according to Informa Pharma Intelligence’s latest global rankings. Sandoz has surpassed troubled Teva into second place but is set to surrender that position following the sale of its US solid-dose and dermatology business to India’s Aurobindo.